Treatment of neurologic functions

Details Treatment of neurologic functions Treatment of neurologic functions

1984-03-30

1986-08-26

Phillips, Delbert R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

A61K 3743

Patent

active

046083650

ABSTRACT:
A treatment is provided for the amelioration of symptoms of amyotrophic lateral sclerosis and other conditions which result from dysfunction of lower or upper motor neurons by the administration of doses of thyrotropin-releasing hormone by intravenous infusion or subcutaneous injection.

REFERENCES:
patent: 3737422 (1973-06-01), Flouret
patent: 3746697 (1973-07-01), Folkers et al.
patent: 3753969 (1973-08-01), Folkers et al.
patent: 3757003 (1973-09-01), Folkers
patent: 3816387 (1974-06-01), Cole et al.
patent: 3833604 (1974-09-01), Schafer
patent: 3860570 (1975-01-01), Thomas
patent: 3873709 (1975-03-01), Plotnikoff
patent: 3912705 (1975-10-01), Fujino et al.
patent: 3932623 (1976-01-01), Wilson et al.
patent: 3959247 (1976-05-01), Fujino et al.
patent: 3959248 (1976-05-01), Veber et al.
patent: 4045556 (1977-08-01), Schwertner et al.
patent: 4066749 (1978-01-01), Veber et al.
patent: 4100152 (1978-07-01), Fujino et al.
patent: 4125605 (1978-11-01), Tyson
patent: 4167563 (1979-09-01), Mikura et al.
patent: 4254261 (1981-03-01), Miller et al.
patent: 4386073 (1983-05-01), Kisfaludy et al.
patent: 4426378 (1984-01-01), Holaday
patent: 4468382 (1984-08-01), Bacha
Sobue et al., "Thyrotropin-Releasing Hormone and Spinocerebellar Degenerations," Neurology, Proceedings of the World Congress of Neurology, Excerpta Medica, 1982, pp. 240-258.
Faden et al., "Thyrotropin-Releasing Hormone Improves Neurologic Recovery After Spinal Trauma in Cats," The New England Journal of Medicine, 1981, vol. 305, No. 18, pp. 1063-1067.
Engel, et al., "Effect on Weakness and Spasticity in Amyotrophic Lateral Sclerosis of Thyrotropin-Releasing Hormone," Lancet, Jun. 9, 1983, pp. 73-75.
John W. Holaday, et al., "Protirelin (TRH)", Arch. Intern. Med., vol. 144, Jun. 1984, pp. 1138-1140.
MDA Colloquium, Muscle & Nerve, Jul./Aug. 1985, p. 463.
Benjamin Rix Brooks, et al., "Extracellular Cyclic Nucleotide Metabolism in the Human Central Nervous System," Neurobiology of Cerebrospinal Fluid, Ed. James H. Wood, M.D., Plenum Press, New York, 1980, pp. 113-139.
Richard B. Mailman, et al., "Change in Brain cGMP Content," Journal of Pharmacology and Experimental Therapeutics, vol. 208, 1979, pp. 169-175.
Richard B. Mailman, et al., "Thyrotropin-Releasing Hormone Reversal of Ethanol Induced Decreases in Cerebellar cGMP," Nature, vol. 272, Apr. 1978, pp. 832-833.
K. Krnjevic, et al., "Is Cyclic Gnuanosine Monophosphate the Internal `Second Messenger` for Cholinergic Actions on Central Neurons?," Can. J. Physio. Pharmacol., vol. 54, 1976, pp. 172-176.
K. Krnjevic, et al., "Cyclic Nucleotides in Spinal Cells," Can. J. Physio. Pharmacol., vol. 54, 1976, pp. 416-421.
Pages from "Neurochemical Alterations in Parkinson's, Disease," Ed. James H. Wood, M.D., Neurobiology of Cerebrospinal Fluid, Plenum Press, New York, 1980, pp. 208-210.
W. King Engel, et al., "Phthalazinol, Thrombocytopenia, and Amyotrophic Lateral Sclerosis," Arch. Neurol., vol. 37, May 1980, p. 320.
Jerry R. Mendell, M.D., et al., "Amyotrophic Lateral Sclerosis," Arch. Neurol., vol. 25, Oct. 1971, pp. 320-325.
Notes of Dr. Engel regarding cAMP and cGMP studies.
Alan I. Faden, et al., "Comparison of Thyrotropin-Releasing Hormone (TRH), Naloxone, and Dexamethasone Treatments in Experimental Spinal Injury," Neurology, vol. 33, Jun. 1983, pp. 673-678.
Alan I. Faden, et al., "Effect of TRH Analogs on Neurologic Recovery After Experimental Spinal Trauma," Neurology, vol. 35, Sep. 1985, pp. 1331-1334.
Alan I. Faden, M.D., "Opiate Antagonists and Thyrotropin-Releasing Hormone," JAMA, Sep. 21, 1984, vol. 252, No. 11, pp. 1452-1454.
Alan I. Faden, et al., "Thyrotropin-Releasing Hormone in Experimental Spinal Injury: Dose Response and Late Treatment," Neurology, vol. 34, Oct. 1984, pp. 1280-1284.
Giora Feuerstein, et al., "Hypotension Produced by Platelet-Activating Factor is Reversed by Throtropin-Releasing Hormone," Circulatory Shock 13, 1984, pp. 255-260.
Warren E. Lux, Jr., et al., "Thyrotropin-Releasing Hormone Reverses Experimental Anaphylactic Shock Through Non-Endorphin-Related Mechanisms," European Journal of Pharmacology, 90, 1983, pp. 301-302.

Affiliated with

Also associated with

Rating

Treatment of neurologic functions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of neurologic functions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of neurologic functions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2312637